Semaglutide (Wegovy) is FDA-approved for weight loss in adults without diabetes — but the criteria are specific, and not everyone who wants it qualifies. This guide covers who is eligible, what the clinical criteria mean, and how to confirm you meet them before booking a visit.

Key Takeaways
  • Semaglutide was first approved as Ozempic for type 2 diabetes in 2017.
  • If you think you qualify, the next step is a consult with a clinician who prescribes semaglutide for weight loss.
  • The most common reason people who qualify for semaglutide don't get it is the belief that you need diabetes.

TL;DR

Semaglutide for weight loss (Wegovy) is indicated for adults with a BMI of 30 or higher, or 27+ with at least one weight-related comorbidity (hypertension, prediabetes, dyslipidemia, sleep apnea, or PCOS). You do not need type 2 diabetes to qualify — that's a common misconception that keeps people from seeking treatment. GoodLife Health clinicians confirm eligibility through BMI calculation and a review of your medical history at intake. Verdict: semaglutide for weight loss without diabetes is a legitimate, FDA-indicated treatment — the barrier is meeting the clinical criteria, not having a diabetes diagnosis.

Why this matters

Semaglutide was first approved as Ozempic for type 2 diabetes in 2017. When the STEP trials demonstrated significant weight loss in patients without diabetes, the FDA approved Wegovy (the same molecule at a higher max dose) specifically for weight management in 2021. Despite this, many patients — and some doctors — still assume you need diabetes to get a GLP-1 prescription.

This misconception delays treatment. If you have a BMI of 30+ (or 27+ with a comorbidity) and have struggled with sustained weight loss through lifestyle changes alone, you may be eligible for semaglutide right now, without a diabetes diagnosis.

What you'll need

  • Your height and current weight (to calculate BMI)
  • A list of any weight-related health conditions you've been diagnosed with (hypertension, prediabetes, dyslipidemia, sleep apnea, PCOS)
  • Your most recent blood pressure reading
  • Recent lab results if you have them (fasting glucose, HbA1c, lipid panel)
  • A history of prior weight loss attempts (diet, exercise, other medications)
  • A clinician who prescribes GLP-1 medications — not all primary care doctors do

The steps

1. Calculate your BMI

BMI is weight in kilograms divided by height in meters squared. A BMI of 30 or higher qualifies you for semaglutide for weight loss without any additional conditions. A BMI of 27-29.9 qualifies you if you also have at least one weight-related comorbidity. Use an online BMI calculator — don't estimate. Common mistake: using your "ideal weight" instead of your actual weight — the criteria use your current BMI.

2. Identify any weight-related comorbidities (if BMI is 27-29.9)

If your BMI is between 27 and 30, you need at least one weight-related condition to qualify. The most common are:

  • Hypertension (high blood pressure)
  • Prediabetes (fasting glucose 100-125 mg/dL or HbA1c 5.7-6.4%)
  • Dyslipidemia (abnormal cholesterol or triglycerides)
  • Sleep apnea
  • PCOS

If you have any of these, you qualify. If you're not sure, ask your clinician to check at intake. Common mistake: assuming you don't have a comorbidity because you haven't been formally diagnosed — many people have prediabetes or hypertension without knowing it.

3. Document prior weight loss attempts

Semaglutide is not a first-line treatment — it's for patients who have not achieved sustained weight loss through lifestyle changes alone. Be prepared to describe what you've tried: specific diets, exercise programs, other medications, and what happened. This doesn't mean you need to have failed at everything — it means you've made a reasonable effort and need additional support. Common mistake: saying you haven't tried anything — this can lead a clinician to recommend lifestyle changes first, delaying the prescription.

4. Get baseline labs ordered

A clinician prescribing semaglutide should order baseline labs before the first dose: fasting glucose or HbA1c, a comprehensive metabolic panel, and a lipid panel. These labs confirm your metabolic picture and establish a baseline for monitoring. Some clinicians also check thyroid function. Common mistake: starting the medication before labs come back — the clinician is then prescribing blind.

5. Confirm the dosing schedule

Semaglutide for weight loss (Wegovy) starts at 0.25mg weekly for 4 weeks, then escalates in 0.25mg increments every 4 weeks up to a maximum of 2.4mg weekly. Your clinician should give you the full escalation schedule at the first visit. Common mistake: expecting to start at the maintenance dose — the titration takes 16-20 weeks to reach 2.4mg.

6. Set up the follow-up cadence

Monthly visits during titration, with lab rechecks at 8-12 week intervals. A clinician who prescribes semaglutide without scheduling follow-up is managing a prescription, not a protocol. Ask for the follow-up schedule before leaving the first visit. Common mistake: accepting "call me if you have problems" as a follow-up plan.

Troubleshooting

Your BMI is 28 and you're not sure if you have a comorbidity. Ask your clinician to check your blood pressure and run a fasting glucose or HbA1c. Many people have undiagnosed hypertension or prediabetes — if either is present, you qualify.

Your doctor says you need diabetes for semaglutide. This is incorrect for Wegovy, which is FDA-approved for weight loss without diabetes. If your doctor insists, ask them to clarify whether they're referring to Ozempic (diabetes indication) or Wegovy (weight loss indication) — or consider a telehealth weight loss clinic that prescribes Wegovy.

Your insurance denied coverage for Wegovy. Ask your clinician's team to submit a prior authorization with documentation of your BMI and comorbidities. If denied, discuss self-pay pricing or compounded semaglutide as an alternative.

You've lost weight on your own before but regained it. This is exactly the pattern semaglutide is designed to address — the STEP trials showed that patients who regained weight after lifestyle programs achieved sustained loss on semaglutide. Prior regain is not a reason to disqualify you.

You're worried about side effects. Nausea, constipation, and fatigue are common in the first 4-8 weeks and typically resolve as the body adjusts. A clinician who manages the protocol can slow the titration if side effects are severe. This is why follow-up matters.

Tools and resources

What to do next

If you think you qualify, the next step is a consult with a clinician who prescribes semaglutide for weight loss. Read about how to talk to your doctor about starting GLP-1 therapy so you're prepared for the conversation.

FAQ

Can you get semaglutide for weight loss without diabetes? Yes — Wegovy (semaglutide for weight loss) is FDA-approved for adults with a BMI of 30+ or 27+ with a weight-related comorbidity, regardless of diabetes status. You do not need type 2 diabetes to qualify.

What BMI do you need for semaglutide without diabetes? A BMI of 30 or higher qualifies without any additional conditions. A BMI of 27-29.9 qualifies if you have at least one weight-related comorbidity such as hypertension, prediabetes, dyslipidemia, sleep apnea, or PCOS.

What's the difference between Ozempic and Wegovy? They're the same molecule (semaglutide). Ozempic is FDA-approved for type 2 diabetes at a max dose of 1.0mg weekly. Wegovy is FDA-approved for weight loss at a max dose of 2.4mg weekly. The higher dose is what drives the greater weight loss seen in the STEP trials.

Do I need to have tried diet and exercise first? Semaglutide is indicated for patients who have not achieved sustained weight loss through lifestyle changes alone. You should be able to describe prior attempts, but you don't need to have exhausted every option — a reasonable effort that didn't produce lasting results is sufficient.

How much weight can you lose on semaglutide without diabetes? The STEP-1 trial showed 14.9% mean weight loss at 68 weeks on the 2.4mg maintenance dose, compared to 2.4% in the placebo group. Individual results vary based on adherence, dose, and lifestyle factors.

Is semaglutide for weight loss covered by insurance? Many plans cover Wegovy with prior authorization, especially if you meet the BMI criteria and have documented comorbidities. Compounded semaglutide is typically not covered. Check with your specific plan.

What if my doctor won't prescribe semaglutide? Not all primary care doctors prescribe GLP-1 medications. Ask for a referral to a weight management specialist or consider a direct primary care membership or telehealth clinic that specializes in medical weight loss.

One last thing

The most common reason people who qualify for semaglutide don't get it is the belief that you need diabetes. You don't — Wegovy is specifically approved for weight loss in adults without diabetes. If your BMI is 30+ (or 27+ with a comorbidity), you may be eligible. The barrier is information, not clinical criteria.

Related guides

References

  1. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
  2. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/